C07D 473/32
Nitrogen atom
C07D473/32 (Nitrogen atom) appears on 1,059 US grants and 1,306 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,059
- Published applications
- 1,306
- Assignees
- 651
- Inventors
- 3,355
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 5 | 0 |
| 1979 | 1 | 0 |
| 1980 | 8 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 11 | 0 |
| 1990 | 5 | 0 |
| 1991 | 10 | 0 |
| 1992 | 9 | 0 |
| 1993 | 12 | 0 |
| 1994 | 7 | 0 |
| 1995 | 6 | 0 |
| 1996 | 7 | 0 |
| 1997 | 15 | 0 |
| 1998 | 6 | 0 |
| 1999 | 15 | 0 |
| 2000 | 23 | 0 |
| 2001 | 16 | 2 |
| 2002 | 22 | 18 |
| 2003 | 19 | 25 |
| 2004 | 17 | 31 |
| 2005 | 13 | 29 |
| 2006 | 16 | 32 |
| 2007 | 17 | 41 |
| 2008 | 20 | 39 |
| 2009 | 25 | 50 |
| 2010 | 16 | 54 |
| 2011 | 23 | 65 |
| 2012 | 41 | 64 |
| 2013 | 45 | 65 |
| 2014 | 62 | 81 |
| 2015 | 66 | 63 |
| 2016 | 59 | 83 |
| 2017 | 60 | 77 |
| 2018 | 70 | 87 |
| 2019 | 73 | 83 |
| 2020 | 60 | 53 |
| 2021 | 30 | 52 |
| 2022 | 37 | 45 |
| 2023 | 15 | 53 |
| 2024 | 21 | 36 |
| 2025 | 23 | 47 |
| 2026 | 21 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- PIKfyve kinase inhibitors22 Sep 2026US 12,741,960 B2Acurastem Incorporated
- Method for labeling nucleic acid11 Aug 2026US 12,703,881 B2Cambridge Enterprise Limited
- Adenosine analog and its use in regulating the circadian clock30 Jun 2026US 12,667,584 B2National Institute of Biological Sciences, Beijing
- Adenosine analogs for the treatment of disease9 Jun 2026US 12,649,740 B2Biointervene, Inc.
- Method of treating microbial infections2 Jun 2026US 12,642,804 B2The Regents of the University of California
- Prmt inhibitor compounds and the uses thereof8 Oct 2026US 2026/0306527 A1Purdue Research Foundation
- Adenosine analog and its use in regulating the circadian clock1 Oct 2026US 2026/0294952 A1National Institute of Biological Sciences, Beijing
- Btk degrading compounds17 Sep 2026US 2026/0274849 A1Beijing neoX Biotech Limited
- Prevention/Treatment of Ischemic Reperfusion Injury10 Sep 2026US 2026/0265280 A1
- Piperidinyl-methyl-purine amine fumaric acid salts, crystalline forms, and their use in treating medical diseases and conditions3 Sep 2026US 2026/0258044 A1K36 Therapeutics, Inc.
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Chemical amplification based on fluid partitioning573US 7,041,481 B2The Regents of the University of California · 2006
- Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same547US 5,130,302 ABoron Bilogicals, Inc. · 1992
- Acyclic nucleoside analogs and oligonucleotide sequences containing them413US 5,576,427 ASterling Winthrop Inc. · 1996
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997